Skip to content
The Centers for Disease Prevention and Control (CDC) recently issued new recommendations to enhance preparedness for the upcoming respiratory virus season. These guidelines focus […]
CDC issues new guidelines to prepare for respiratory virus season Read More »
Talus Bio’s collaborative and innovative approach to unlocking the therapeutic potential of targeting transcription factors for cancer and other diseases is putting them at
John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), highlighted the crucial themes of “innovation, access, and advocacy” during his keynote
Injecting medicine can be a scary prospect. It is not just the fear of needles that can prevent patients from self-administration. Even traditional auto-injector
NIH Innovation Zone 2024: Pirouette Medical is innovating safer, easier auto-injections Read More »
A bill to reauthorize a program that encourages the development of pediatric rare disease treatments was introduced in the Senate on June 20. Bill
Pediatric Priority Review Voucher reauthorization introduced in Senate Read More »
“ALS is a devastating disease.” This is a common refrain when talking about Amyotrophic Lateral Sclerosis (ALS), a nervous system disease that weakens muscles
Unlocking hope: AMP ALS is transforming ALS biomarker research Read More »
Artificial intelligence (AI) is on everyone’s mind these days. In healthcare and biotech, AI is addressing some of the industry’s biggest challenges, as well
NIH Innovation Zone 2024: Modality.AI tackles remote neurological assessment Read More »
June 19 is a day of dual significance: World Sickle Cell Day and Juneteenth. It’s a day of celebration, acknowledging the remarkable progress in
World Sickle Cell Day 2024: A day to celebrate, a day to reflect Read More »
In implementing the Inflation Reduction Act (IRA), the Centers for Medicare and Medicaid Services (CMS) has made efforts to unnecessarily broaden the law with
CMS overreach will impede innovation Read More »
The U.S. Food and Drug Administration (FDA) approved the CAPVAXIVE™ vaccine to protect adults from bacteria that can cause pneumonia and invasive pneumococcal disease
FDA approves Merck’s vaccine against pneumococcus bacteria Read More »
